Real-time enrollment status for this generalized epilepsy clinical trial
Current Status
Terminated
Checked: April 17, 2026 at 2:08 AM UTC
| NCT Number | NCT06425159 |
| Recruiting Status | Terminated |
| Condition | Generalized Epilepsy |
| Phase | Clinical Trial |
| Target Enrollment | 242 participants |
| Active Locations | 46 sites in the US |
| Sponsor | Biohaven Therapeutics Ltd. |
| Last Updated on CT.gov | March 24, 2026 (3 weeks ago) |
As of April 17, 2026: Clinical trial NCT06425159 is currently terminated participants. This clinical trial study for generalized epilepsy is not currently accepting new participants at 46 locations across the United States. The study is sponsored by Biohaven Therapeutics Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06425159 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 46 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06425159 was last updated 3 weeks ago (March 24, 2026). HelloStudys verifies this status automatically.